Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06911177

Yeast Mannans and Stool Frequency

Efficacy of Yeast Mannan Supplementation on Increasing Stool Frequency in Generally Healthy Adults: A Randomized Controlled Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Findings from an open-label pilot study of 20 adults suggested that supplementation with 15 g/day of yeast mannans was highly tolerable and demonstrated specific modulation of the microbiota and increased stool frequency in a subset of subjects reporting ≤1 stool per day at baseline. The primary aim of this randomized, double-blind, controlled trial is to determine if yeast mannan supplementation at 12 g/day will increase stool frequency in generally healthy adults reporting ≤1 stool per day. Secondary aims will determine the effect of yeast mannans on intestinal transit time, gastrointestinal symptoms, fecal microbiota composition, and urinary and fecal metabolomics.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTYeast mannanYeast cell wall fraction of manno-oligosaccharides and mannoproteins supplemented at 12 g/day.
DIETARY_SUPPLEMENTControl (placebo)A supplement containing yeast protein, yeast extract, and maltodextrin, provided at 12 g/day.

Timeline

Start date
2025-07-17
Primary completion
2026-03-16
Completion
2026-12-31
First posted
2025-04-04
Last updated
2026-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06911177. Inclusion in this directory is not an endorsement.